6 results
Thrombolytics for stroke: The evidence - 
A summary of the evidence for (or against) thrombolytics for
stroke: The evidence ... summary of the evidence ... #EBM #Neurology ... #Stroke #RCT #Evidence ... Summary #TPADebate #Controversy
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
History of Systemic Thrombolysis ... Rezaie @srrezaie #EBM ... #Thrombolytics ... #Evidence #Summary ... #TPADebate #Controversy
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Honc #Osimertinib ... #NSCLC #Survival ... #NEJM
Common Arguments and Rebuttals on tPA in Acute Stroke - George Mastoras, MD @georgemastoras
#EBM #Neuro #Stroke
georgemastoras #EBM ... Stroke #TPADebate #Controversy ... #Thrombolysis # ... Evidence #Summary
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
#EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM